期刊文献+

降钙素原以及C-反应蛋白对于手术后脓毒血症患者的预后影响 被引量:1

Calcitonin and C-reactive Protein on the Prognosis of Patients with Postoperative Sepsis
在线阅读 下载PDF
导出
摘要 目的分析研究降钙素原以及C-反应蛋白对于手术后脓毒血症患者的预后影响。方法抽取2012年3月至2015年11月我院接收的62例脓毒血症患者作为研究对象,在第1、5、10天对患者降钙素原以及C-反应蛋白水平进行序贯性检测,观察分析患者转归情况、降钙素原以及C-反应蛋白水平变化情况,并依据APACHEⅡ评分标准对患者急性生理与慢性健康状况进行评分。结果本研究62例患者治疗1个月后41例存活,为预后良好组;21例死亡,分为预后较差组;两组降钙素原及C-反应蛋白和APACHEⅡ评分在第1天差异无统计学意义(P>0.05),两组降钙素原及C-反应蛋白和APACHEⅡ评分在第5和第10天差异显著(P<0.05)。结论降钙素原以及C-反应蛋白水平与脓毒血症具有极大相关性,可通过联合检测降钙素原以及C-反应蛋白水平作为术后脓毒血症患者的诊断指标,值得推广运用。 Objective To analyze the prognosis for patients with sepsis after surgery procaleitonin and C-reactive protein. Methods 62 cases of sepsis patients were selected as the research object from March 2013 to November 2015 in our hospital, at 1, 5, 10 d patient proealcitonin and C-reactive protein levels were sequential testing.Patient outcomes, calcitonin and C-reactive protein level change situation was observed and analyzed, and based the APACHE Ⅱ score of patients with acute physiology and chronic health score. Results In this study, 62 patients were treated for 1 months, 41 patients survived and 21 patients died, and the prognosis was poor; Two procalcitonin and C-reactive protein and APACHE Ⅱ score at 1 d was no significant difference (P〉0.05); Two groups of proealcitonin and C reactive protein and APACHE Ⅱ in fifth and 10d scores were significantly difference (P〈0.05). Conclusion Calcitonin and C-reaction protein levels and sepsis has great relevance, by combined detection of calcitonin) and C-reactive protein level as the index to diagnose postoperative sepsis patients, it is worth to promote the use of.
作者 杨林
出处 《中国医药指南》 2017年第15期14-15,共2页 Guide of China Medicine
关键词 降钙素原 C-反应蛋白 脓毒血症 Procalcitonin C- reactive protein Sepsis
  • 相关文献

参考文献8

二级参考文献78

  • 1高旭,许传亮,陈策,高小峰,王林辉,孙颖浩.输尿管镜下钬激光碎石术后重症感染诊治体会(附专家点评)[J].中华泌尿外科杂志,2005,26(1):33-35. 被引量:209
  • 2Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol, 2009, 20 (1):223-228.
  • 3Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med, 1992, 20(6):724-726.
  • 4Klenzak J, Himmelfarb J. Sepsis and the kidney. Crit Care Clin, 2005, 21(2):211-222.
  • 5Nie X, Wu B, He Y, et al. Serum procalcitonin predicts development of acute kidney injury in patients with suspected infection. Clin Chem Lab Med, 2013, 51(8):1655-1661.
  • 6Christ-Crain M, Opal SM, Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care, 2010, 14(1):203.
  • 7Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, muhicenter study. JAMA, 2005, 294(7):813-818.
  • 8陈山,魏金星,陈斌,等.泌尿系感染诊断治疗指南[M]//那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南:2014版.北京:人民卫生出版社,2013:424.434.
  • 9Auriti C, Fiscarelli E, Ronehetti MP, et al. Procalcitonin in de- tecting neonatal nosoeomial sepsis [ J ]. Arch Dis Child Fetal Neonatal Ed, 2012, 97: F368-370.
  • 10Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomark- ers of sepsis in critical care [ J]. J Antimicrob Chemother, 2011, 66 Suppl 2: $33-40.

共引文献117

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部